J. Galon, F. Pagès, F. Marincola, M. Thurin, G. Trinchieri et al., The immune score as a new possible approach for the classification of cancer, Journal of Translational Medicine, vol.10, issue.1, 2012.
DOI : 10.1186/1479-5876-9-32

URL : https://hal.archives-ouvertes.fr/inserm-00664981

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea et al., Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction, Journal of Clinical Oncology, vol.29, issue.6, pp.610-618, 2011.
DOI : 10.1200/JCO.2010.30.5425

F. Pagès, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini et al., In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-5951, 2009.
DOI : 10.1200/JCO.2008.19.6147

W. Fridman, F. Pages, C. Sautes-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1038/nrc3245

N. Eiró, I. Pidal, B. Fernandez-garcia, S. Junquera, M. Lamelas et al., Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast Cancer, PLoS ONE, vol.184, issue.12, p.52796, 2012.
DOI : 10.1371/journal.pone.0052796.t004

D. Denardo, D. Brennan, E. Rexhepaj, B. Ruffell, S. Shiao et al., Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011.
DOI : 10.1158/2159-8274.CD-10-0028

A. Cochran, D. Wen, Z. Farzad, M. Stene, W. Mcbride et al., Immune suppression by melanoma cells as a factor in the generation of metastatic disease, Anticancer Res, vol.9, pp.859-864, 1989.

A. Cochran, D. Morton, S. Stern, A. Lana, R. Essner et al., Sentinel Lymph Nodes Show Profound Downregulation of Antigen-Presenting Cells of the Paracortex: Implications for Tumor Biology and Treatment, Modern Pathology, vol.14, issue.6, pp.604-608, 2001.
DOI : 10.1038/modpathol.3880358

F. Hodi, O. Day, S. Mcdermott, D. Weber, R. Sosman et al., Improved Survival with Ipilimumab in Patients with Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.8, pp.711-723, 2010.
DOI : 10.1056/NEJMoa1003466

P. Ascierto, E. Simeone, M. Sznol, Y. Fu, and I. Melero, Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies, Seminars in Oncology, vol.37, issue.5, pp.508-516, 2010.
DOI : 10.1053/j.seminoncol.2010.09.008

J. Kline and T. Gajewski, Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer, Curr Opin Investig Drugs, vol.11, pp.1354-1359, 2011.

A. Weinberg, N. Morris, M. Kovacsovics-bankowski, W. Urba, and B. Curti, Science gone translational: the OX40 agonist story, Immunological Reviews, vol.37, issue.1, pp.218-231, 2011.
DOI : 10.1111/j.1600-065X.2011.01069.x

O. Hamid, H. Schmidt, A. Nissan, L. Ridolfi, S. Aamdal et al., A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma, Journal of Translational Medicine, vol.9, issue.1, p.204, 2011.
DOI : 10.1097/CJI.0b013e31817fd8f3

S. Topalian, F. Hodi, J. Brahmer, S. Gettinger, D. Smith et al., Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, Sznol M: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, pp.2443-2454, 2012.
DOI : 10.1056/NEJMoa1200690

P. Ascierto, M. Kalos, D. Schaer, M. Callahan, and J. Wolchok, Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types, Clinical Cancer Research, vol.19, issue.5, 2013.
DOI : 10.1158/1078-0432.CCR-12-2982

D. Coppola, M. Nebozhyn, F. Khalil, H. Dai, T. Yeatman et al., Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array Profiling, The American Journal of Pathology, vol.179, issue.1
DOI : 10.1016/j.ajpath.2011.03.007

J. Messina, D. Fenstermacher, S. Eschrich, X. Qu, A. Berglund et al., 12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?, Scientific Reports, vol.68, p.765, 2012.
DOI : 10.1038/srep00765

. Ascierto, The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment, Journal of Translational Medicine, vol.11, issue.1, p.54, 2013.
DOI : 10.1016/j.ajpath.2011.03.007

URL : https://hal.archives-ouvertes.fr/inserm-00804641